Literature DB >> 2166183

Muscle cell cultures in Menkes' disease: copper accumulation in myotubes.

G J van den Berg1, J J Kroon, F A Wijburg, K M Sinjorgo, N H Herzberg, P A Bolhuis.   

Abstract

We present 64Cu uptake studies in cultured muscle cells from a one-year-old patient with Menkes' disease. The cultured muscle cells from the patient showed a five-fold higher 64Cu uptake than control muscle cells. Copper uptake in muscle cells was of the same magnitude as that found in fibroblasts from the patient and also from other Menkes' patients. The copper content of a muscle biopsy from the patient was twice that of a control biopsy. The enhanced uptake is probably copper specific, since zinc uptake was unaltered in both muscle cells and fibroblasts from the patient. Cytochrome c oxidase in the muscle of the patient was reduced to one-third of the value for controls, which is in agreement with the hypothesis that in Menkes' disease copper accumulates in a biologically non-active form. However, in cultured muscle cells and fibroblasts from the patient the cytochrome c oxidase activity was in the normal range, probably because of the relatively large amount of copper already available in the culture medium.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166183     DOI: 10.1007/BF01799687

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  18 in total

1.  Cytochrome c oxidase: organ-specific isoenzymes and deficiencies.

Authors:  K M Sinjorgo; T B Hakvoort; A O Muijsers; A W Schram; J M Tager
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

2.  Rapid cell culture procedure for tissue samples.

Authors:  B A Gray; S M Gollin
Journal:  Am J Med Genet       Date:  1987-10

3.  Free-energy carriers in human cultured muscle cells.

Authors:  P A Bolhuis; H J de Zwart; N J Ponne; J M de Jong
Journal:  Muscle Nerve       Date:  1985-01       Impact factor: 3.217

4.  Menkes' kinky hair syndrome: a genetic disease involving copper.

Authors:  N A Holtzman
Journal:  Fed Proc       Date:  1976-09

Review 5.  Tissue culture studies of muscle disorders: Part 2. Biochemical studies, nerve-muscle culture, metabolic myopathies, and animal models.

Authors:  J A Witkowski
Journal:  Muscle Nerve       Date:  1986-05       Impact factor: 3.217

Review 6.  Tissue culture studies of muscle disorders: Part 1. Techniques, cell growth, morphology, cell surface.

Authors:  J A Witkowski
Journal:  Muscle Nerve       Date:  1986 Mar-Apr       Impact factor: 3.217

7.  Copper utilization in cultured skin fibroblasts of the mottled mouse, an animal model for Menkes' kinky hair syndrome.

Authors:  S Packman; P Chin; C O'Toole
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Menkes X-linked disease: prenatal diagnosis of hemizygous males and heterozygous females.

Authors:  N Horn
Journal:  Prenat Diagn       Date:  1981-04       Impact factor: 3.050

9.  Copper-measurement in a muscle-biopsy. A possible method for postmortem diagnosis of Menkes disease.

Authors:  T Tønnesen; G Müller-Schauenburg; E Damsgaard; N Horn
Journal:  Clin Genet       Date:  1986-03       Impact factor: 4.438

10.  Abnormal copper-thionein synthesis and impaired copper utilization in mutated brindled mice: model for Menkes' disease.

Authors:  H W Prins; J A Van den Hamer
Journal:  J Nutr       Date:  1980-01       Impact factor: 4.798

View more
  2 in total

1.  Counteract of bone marrow of blotchy mice against the increases of plasma copper levels induced by high-fat diets in LDLR-/- mice.

Authors:  Jessica Yao; Zhenyu Qin
Journal:  J Trace Elem Med Biol       Date:  2015-02-21       Impact factor: 3.849

2.  Bone marrow from blotchy mice is dispensable to regulate blood copper and aortic pathologies but required for inflammatory mediator production in LDLR-deficient mice during chronic angiotensin II infusion.

Authors:  Devon Harris; Yuanyuan Liang; Cang Chen; Senlin Li; Om Patel; Zhenyu Qin
Journal:  Ann Vasc Surg       Date:  2014-10-29       Impact factor: 1.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.